ROUNDTABLE: Discussing the Influence of Post-Translation Modifications & Other Manufacturing Considerations on Gene Therapy Vector Potency to Better Define Relevant CQAs
Time: 10:30 am
day: Day 2
Details:
Roundtable discussions include a larger focus on group discussion. A moderator will introduce the session topic and attendees then split into groups to discuss a series of predetermined agenda points. At the end, all groups report back on their discussions, and findings are collated.
This roundtable will cover:
- Balancing quality with quantity of reference standards – How do you ensure sufficient quantity of viral vectors for clinical supply?
- Selecting appropriate cell lines in the generation of reference materials
- Establishing protocols for dealing with small batches of reference standards and low sample numbers
